---
title: "Insider Shake-Up at Hinge Health as Director Executes Notable Stock Sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296663892.md"
description: "Hinge Health director Kristina Leslie sold 1,200 shares worth $105,876 on August 21, 2026. This insider move follows a strong Q2 earnings report featuring rapid revenue growth and raised guidance. Despite the sale, TipRanks' AI Analyst rates HNGE as an 'Outperform,' citing strong operating momentum and cash generation, though historical volatility remains a factor."
datetime: "2026-08-22T02:09:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296663892.md)
  - [en](https://longbridge.com/en/news/296663892.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296663892.md)
generator: "portal-rs"
---

# Insider Shake-Up at Hinge Health as Director Executes Notable Stock Sale

New insider activity at Hinge Health, Inc. Class A ( (HNGE) ) has taken place on August 21, 2026.

Director Kristina Leslie has sold 1,200 shares of Hinge Health, Inc. Class A stock in a transaction valued at $105,876, signaling a notable insider move at the digital musculoskeletal care company.

Hinge Health, Inc. Class A shares reacted to a very strong Q2 earnings report that showed rapid revenue and billings growth, sharply higher margins, and surging free cash flow, alongside raised full‑year guidance. Analysts also cited the accretive Cylinder Health acquisition, expanding multi-condition platform, and strong operating momentum as key reasons for raising their price targets, despite management’s conservative billings outlook and integration risks.

**Spark’s Take on HNGE Stock**

According to Spark, TipRanks’ AI Analyst, HNGE is a Outperform.

The score is driven primarily by strong operating momentum and raised forward guidance from the latest earnings call, supported by improving cash generation and a low-debt balance sheet. Offsetting factors include significant historical earnings volatility (large 2025 net loss), a mixed near-term technical picture, and limited traditional valuation support due to negative earnings and no stated dividend yield.

To see Spark’s full report on HNGE stock,  
 click here. 

**More about Hinge Health, Inc. Class A**

**YTD Price Performance:** 84.33%

**Average Trading Volume:** 1,943,830

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $7.14B

### Related Stocks

- [HNGE.US](https://longbridge.com/en/quote/HNGE.US.md)

## Related News & Research

- [One Platform, Every Ailment: Hinge Health's Gamble](https://longbridge.com/en/news/296483875.md)
- [Hinge Health director Elliott Robinson reports disposal of shares worth $2.36 million](https://longbridge.com/en/news/296654345.md)
- [3 arguments for and against AI watermarks](https://longbridge.com/en/news/296205500.md)
- [The push for AI watermarks is spawning a new wave of tools to remove them](https://longbridge.com/en/news/296262434.md)
- [Dividend 15 Split declares monthly distribution of $0.10 per Class A share and $0.06 per preferred share](https://longbridge.com/en/news/296360173.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**